Tamás Pintér

13.7k citations
43 papers · 10.2k · 3 hit papers · h-index 21

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Treatment and Pharmacology 9
    • HER2/EGFR in Cancer Research 4
    • Colorectal Cancer Treatments and Studies 4
    • Lung Cancer Research Studies 2
    • Pancreatic and Hepatic Oncology Research 2
    • Breast Cancer Treatment Studies 7

Tamás Pintér

38 papers receiving 9.8k citations

Tamás Pintér's Hit Papers

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study 2014 · 1.6k citations
1.6k0+5+11Years since publication10002.0k3.0k

Peers

Tamás Pintér
Comparison fields: 5 of 121
  • Oncology 6.2k
  • Cancer Research 2.2k
  • Pulmonary and Respiratory Medicine 2.7k
  • Hepatology 598
  • Genetics 444
Replace Jonathan A. Polikoff with:
Jonathan A. Polikoff United States
Napoleone Ferrara United States
Gwen Fyfe United States
Mikhail Lichinitser Russia
William J. Heim United States
Marcia S. Brose United States
Petri Bono Finland
István Láng Hungary
Ferry A.L.M. Eskens Netherlands
Robert L. Justice United States
Tamás Pintér relative to Jonathan A. Polikoff United States Jonathan A. Polikoff's profile →
Citations per field
00.5×1.5×2.1×
Jonathan A. Polikoff · 1×
Citations per year

Countries citing papers authored by Tamás Pintér

Since Specialization
Citations

This map shows the geographic impact of Tamás Pintér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamás Pintér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamás Pintér more than expected).

Fields of papers citing papers by Tamás Pintér

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamás Pintér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamás Pintér. The network helps show where Tamás Pintér may publish in the future.

Co-authors

The 25 scholars most cited alongside Tamás Pintér, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tamás Pintér Line = papers co-authored together Tamás Pintér links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Hit paper breakdown →
20093200
2
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Hit paper breakdown →
20112157
3
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Hit paper breakdown →
20141590
4 2005775
5 1999559
6 2003315
7 2012180
8 2008170
9 2008166
10 2016152
11 2020135
12 2004127
13 2012120
14 2013114
15 2022104
16 200485
17 201169
18
Topoisomerase II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated with single-agent doxorubicin or single-agent docetaxel
200443
19 200927
20 201624

About Tamás Pintér

Tamás Pintér is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Reproductive Medicine and Hematology, having authored 43 papers that have together received 10.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (7 papers), Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Research Studies (2 papers), Brain Metastases and Treatment (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Oncology (6.2k citations), Cancer Research (2.2k citations), Pulmonary and Respiratory Medicine (2.7k citations), Hepatology (598 citations) and Genetics (444 citations). Tamás Pintér has collaborated with scholars based in Hungary, Germany and United States. Frequent co-authors include Jerzy Załuski, Jae Kyung Roh, Geert D’Haens, Erika Hitre, Gunnar Folprecht, Philippe Rougier, Gyorgy Bodoky, Anatoly Makhson, Robert Lim and Claus-Henning Köhne. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, New England Journal of Medicine, Breast Cancer Research and Treatment and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact